Literature DB >> 17981761

The role of signal transducers and activators of transcription in colon cancer.

Lidija Klampfer1.   

Abstract

A family of latent cytoplasmic transcription factors, Signal Transducers and Activators of Transcription (STATs), convey signals from numerous cytokines and growth factors to the nucleus. Their expression and their activity have been shown to be perturbed in a variety of malignancies, including colorectal cancer. Among the STAT family members, oncogenic STAT3 has been shown to be constitutively activated or overexpressed in colon cancers. In contrast, the expression levels of STAT1 have been found to be reduced in transformed intestinal epithelial cells, consistent with tumor suppressor properties of STAT1. We showed that transformation of intestinal epithelial cells with KRasV12 is sufficient to downregulate the expression of STAT1. Because both STAT1 and STAT3 are important regulators of genes that are involved in cell survival (BCL-x, survivin, caspases) and cell proliferation (c-Myc, p21, cyclin D1), their deregulation significantly impacts the homeostasis of intestinal tissues. The critical role of STATs in oncogenesis and in inflammation merits further investigation of targeted inhibitors of STATs activity that could be used alone or in combination with conventional chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981761     DOI: 10.2741/2893

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  42 in total

Review 1.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

2.  Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.

Authors:  Gaurav Kumar; S Nahum Goldberg; Svetlana Gourevitch; Tatyana Levchenko; Vladimir Torchilin; Eithan Galun; Muneeb Ahmed
Journal:  Radiology       Date:  2017-09-06       Impact factor: 11.105

3.  Phospho-STAT5 expression is associated with poor prognosis of human colonic adenocarcinoma.

Authors:  Yin-Ling Mao; Zhi-Wei Li; Chang-Jie Lou; Da Pang; Yan-Qiao Zhang
Journal:  Pathol Oncol Res       Date:  2011-01-14       Impact factor: 3.201

4.  STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers.

Authors:  Teppei Morikawa; Yoshifumi Baba; Mai Yamauchi; Aya Kuchiba; Katsuhiko Nosho; Kaori Shima; Noriko Tanaka; Curtis Huttenhower; David A Frank; Charles S Fuchs; Shuji Ogino
Journal:  Clin Cancer Res       Date:  2011-02-10       Impact factor: 12.531

5.  Cell-cell contacts induce STAT3 activity in colon carcinoma cells through an autocrine stimulation loop.

Authors:  Svetlana A Tsareva; Stefan Wagner; Annekatrin Müller; Florian Corvinus; Karlheinz Friedrich
Journal:  J Cancer Res Clin Oncol       Date:  2010-09-10       Impact factor: 4.553

6.  Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway.

Authors:  Debasmita Mandal; Alan D Levine
Journal:  Inflamm Bowel Dis       Date:  2010-05       Impact factor: 5.325

7.  Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.

Authors:  José M Escandell; Pawan Kaler; M Carmen Recio; Takehiko Sasazuki; Senji Shirasawa; Leonard Augenlicht; José-Luis Ríos; Lidija Klampfer
Journal:  Biochem Pharmacol       Date:  2008-05-08       Impact factor: 5.858

8.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

9.  Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3.

Authors:  Zhu Zhang; Jingping Xing; Li Ma; Rujun Gong; Y Eugene Chin; Shougang Zhuang
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

10.  Endogenous suppression of mast cell development and survival by IL-4 and IL-10.

Authors:  Kelly Speiran; Daniel P Bailey; Josephine Fernando; Matthew Macey; Brian Barnstein; Motunrayo Kolawole; Dana Curley; Stephanie S Watowich; Peter J Murray; Carole Oskeritzian; John J Ryan
Journal:  J Leukoc Biol       Date:  2009-02-19       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.